TrialHaematologica2023

Tislelizumab with gemcitabine and oxaliplatin in patients with relapsed or refractory classic Hodgkin lymphoma: a multicenter phase II trial.

Kaiyang Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.